日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Pharmacokinetic Evaluation of GB-5001, a Long-Acting Injectable Formulation of Donepezil, in Healthy Korean Participants: Population Pharmacokinetics with Phase 1 Study

在健康韩国受试者中对长效注射用多奈哌齐制剂GB-5001进行药代动力学评价:基于I期研究的群体药代动力学研究

Park, Ye Chan; Seol, Eunyoung; Lee, Jongmi; Hong, Jang Hee; Jung, Jin-Gyu; Sunwoo, Jung

Population Pharmacokinetic Modeling and Simulation for Dose Optimization of GB-5001, a Long-Acting Intramuscular Injection of Donepezil, in Healthy Participants

在健康受试者中,采用群体药代动力学模型和模拟方法优化长效肌注多奈哌齐(GB-5001)的剂量。

Khwarg, Juyoung; Lee, Heeyong; Yu, Kyung-Sang; Seol, Eunyoung; Chung, Jae-Yong

Donepezil ameliorates Aβ pathology but not tau pathology in 5xFAD mice

多奈哌齐可改善 5xFAD 小鼠的 Aβ 病理,但对 tau 病理无影响。

Choi, Hee-Jeong; Park, Jin-Hee; Jeong, Yoo Joo; Hwang, Jeong-Woo; Lee, Soojung; Lee, Heeyong; Seol, Eunyoung; Kim, Ik-Whi; Cha, Byung-Yoon; Seo, Jinsoo; Moon, Minho; Hoe, Hyang-Sook

Donepezil Regulates LPS and Aβ-Stimulated Neuroinflammation through MAPK/NLRP3 Inflammasome/STAT3 Signaling.

多奈哌齐通过 MAPK/NLRP3 炎症小体/STAT3 信号通路调节 LPS 和 Aβ 刺激的神经炎症

Kim Jieun, Lee Hyun-Ju, Park Seon Kyeong, Park Jin-Hee, Jeong Ha-Ram, Lee Soojung, Lee Heeyong, Seol Eunyoung, Hoe Hyang-Sook